The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes
Abstract
C-reactive protein (CRP) has been shown to be associated with type 2 diabetes, but whether CRP has a causal role is not yet clear. We examined the association in the Rotterdam Study, a population-based prospective cohort study. The association of baseline serum CRP and incident diabetes during follow-up was investigated, and a meta-analysis was conducted on the BMI-adjusted relation of CRP and diabetes. Furthermore, the association of CRP haplotypes with serum CRP and risk of diabetes was assessed. The age- and sex-adjusted hazard ratio for diabetes was 1.41 (95% CI 1.29–1.54) per 1 SD increase in natural logarithm of CRP, and it was 1.88, 2.16, and 2.83 for the second, third, and fourth quartiles of CRP, respectively, compared with the first quartile. The risk estimates attenuated but remained statistically significant after additional adjustment for obesity indexes, which agreed with the results of the meta-analysis. The most common genetic haplotype was associated with a significantly lower CRP level compared with the three other haplotypes. The risk of diabetes was significantly higher in the haplotype with the highest serum CRP level compared with the most common haplotype (OR 1.45, 95% CI 1.08–1.96). These findings support the hypothesis that serum CRP enhances the development of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language for Data Analysis and Graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,220
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M., & Poland, G. A. (2002) · The American Journal of Human Genetics · doi:10.1086/338688 · Cited by 1,783
Advanced methods in meta‐analysis: multivariate approach and meta‐regression
van Houwelingen, H. C., Arends, L. R., & Stijnen, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1040 · Cited by 1,580
Self-citationPhysiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ
Trayhurn, P., & Beattie, J. H. (2001) · Proceedings of the Nutrition Society · doi:10.1079/pns200194 · Cited by 1,259
Determinants of disease and disability in the elderly: The Rotterdam elderly study
Hofman, A., Grobbee, D. E., De Jong, P. T. V. M., & Van den Ouweland, F. A. (1991) · European Journal of Epidemiology · doi:10.1007/bf00145007 · Cited by 1,129
Self-citationFesta, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes
Duncan, B. B., Schmidt, M. I., Pankow, J. S., Ballantyne, C. M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A. R., & Heiss, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1799 · Cited by 1,036
Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women
Hu, F. B., Meigs, J. B., Li, T. Y., Rifai, N., & Manson, J. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.693 · Cited by 788 · cited 3×
“However, some studies found that obesity does not explain the association of CRP with diabetes completely, suggesting an independent role for CRP in the development of diabetes (1,5,9).”
BackgroundFreeman, D. J., Norrie, J., Caslake, M. J., Gaw, A., Ford, I., Lowe, G. D. O., O’Reilly, D. S. J., Packard, C. J., Sattar, N., & for the West of Scotland Coronary Prevention Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1596 · Cited by 728
Body mass index, diabetes, and C-reactive protein among U.S. adults.
Ford, E. S. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.1971 · Cited by 644
The Relation of Markers of Inflammation to the Development of Glucose Disorders in the Elderly
Barzilay, J. I., Abraham, L., Heckbert, S. R., Cushman, M., Kuller, L. H., Resnick, H. E., & Tracy, R. P. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2384 · Cited by 545
Han, T. S., Sattar, N., Williams, K., Gonzalez-Villalpando, C., Lean, M. E. J., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2016 · Cited by 513
Estimation and Tests of Haplotype-Environment Interaction when Linkage Phase Is Ambiguous
Lake, S. L., Lyon, H., Tantisira, K., Silverman, E. K., Weiss, S. T., Laird, N. M., & Schaid, D. J. (2003) · Human Heredity · doi:10.1159/000071811 · Cited by 430
Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study
Pankow, J. S., Folsom, A. R., Cushman, M., Borecki, I. B., Hopkins, P. N., Eckfeldt, J. H., & Tracy, R. P. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00586-4 · Cited by 375
Thorand, B., Löwel, H., Schneider, A., Kolb, H., Meisinger, C., Fröhlich, M., & Koenig, W. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.93 · Cited by 368
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study
Timpson, N. J., Lawlor, D. A., Harbord, R. M., Gaunt, T. R., Day, I. N., Palmer, L. J., Hattersley, A. T., Ebrahim, S., Lowe, G. D., Rumley, A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67786-0 · Cited by 343
Inflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima Indian
Krakoff, J., Funahashi, T., Stehouwer, C. D. A., Schalkwijk, C. G., Tanaka, S., Matsuzawa, Y., Kobes, S., Tataranni, P. A., Hanson, R. L., Knowler, W. C., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1745 · Cited by 334
Carlson, C. S., Aldred, S. F., Lee, P. K., Tracy, R. P., Schwartz, S. M., Rieder, M., Liu, K., Williams, O. D., Iribarren, C., Lewis, E. C., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/431366 · Cited by 324
Russell, A. I. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh021 · Cited by 294
Hingorani, A., & Humphries, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67767-7 · Cited by 277
Harris, M. I., Eastman, R. C., Cowie, C. C., Flegal, K. M., & Eberhardt, M. S. (1997) · Diabetes Care · doi:10.2337/diacare.20.12.1859 · Cited by 264
Nitsch, D., Molokhia, M., Smeeth, L., DeStavola, B. L., Whittaker, J. C., & Leon, D. A. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj062 · Cited by 227
Association of Common CRP Gene Variants with CRP Levels and Cardiovascular Events
Miller, D. T., Zee, R. Y. L., Suk Danik, J., Kozlowski, P., Chasman, D. I., Lazarus, R., Cook, N. R., Ridker, P. M., & Kwiatkowski, D. J. (2005) · Annals of Human Genetics · doi:10.1111/j.1529-8817.2005.00210.x · Cited by 220
Szalai, A. J., Wu, J., Lange, E. M., McCrory, M. A., Langefeld, C. D., Williams, A., Zakharkin, S. O., George, V., Allison, D. B., Cooper, G. S., et al. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0658-0 · Cited by 181
Nakanishi, S., Yamane, K., Kamei, N., Okubo, M., & Kohno, N. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2754 · Cited by 161
Kovacs, A., Green, F. R., Hansson, L., Lundman, P., Samnegård, A., Boquist, S., Ericsson, C.-G., Watkins, H. C., Hamsten, A., & Tornvall, P. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.018 · Cited by 136
DiStefano, J. K., Gruber, J. D., Ossowski, V., de Courten, B. V., Tataranni, P. A., Bogardus, C., & Hanson, R. L. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00230-5 · Cited by 92
Chen, J., Zhao, J., Huang, J., Su, S., Qiang, B., & Gu, D. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0585-5 · Cited by 67
Lim, S. K., Lee, H., Kimm, K.-C., Park, C., Shin, C., & Cho, N. H. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.02.020 · Cited by 62
Insulin, hypertension and antihypertensive drugs in elderly patients: the Rotterdam Study
Stolk, R. P., Hoes, A. W., Pols, H. A., Albert Hofman, D., de Jong, P. T. V. M., Lamberts, S. W. J., & Grobbee, D. E. (1996) · Journal of Hypertension · doi:10.1097/00004872-199602000-00013 · Cited by 11
Cited by
The Rotterdam Study: objectives and design update
Hofman, A., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A., Stricker, B. H. C., Tiemeier, H., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9199-x · Cited by 1,395
Self-citationInflammatory markers in population studies of aging
Singh, T., & Newman, A. B. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.11.002 · Cited by 863
Inflammatory Markers and Risk of Type 2 Diabetes
Wang, X., Bao, W., Liu, J., OuYang, Y.-Y., Wang, D., Rong, S., Xiao, X., Shan, Z.-L., Zhang, Y., Yao, P., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0702 · Cited by 820
High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes
Dehghan, A., van Hoek, M., Sijbrands, E. J. G., Hofman, A., & Witteman, J. C. M. (2008) · Diabetes Care · doi:10.2337/dc07-1276 · Cited by 652
Self-citationDehghan, A., Dupuis, J., Barbalic, M., Bis, J. C., Eiriksdottir, G., Lu, C., Pellikka, N., Wallaschofski, H., Kettunen, J., Henneman, P., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.948570 · Cited by 511
Self-citation
Metadata
- Authors
- Dehghan, A., Kardys, I., de Maat, M. P. M., Uitterlinden, A. G., Sijbrands, E. J. G., Bootsma, A. H., Stijnen, T., Hofman, A., Schram, M. T., & Witteman, J. C. M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2007-03-01
- Volume
- 56
- Issue
- 3
- Pages
- 872-878
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2111803150
- Cited by
- 257
- References
- 33
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.